Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1141 to 1149 of 1149 entries
Sorted by: Best Match Show Resources per page
Mixed- versus predilution hemodiafiltration effects on convection volume and small and middle molecule clearance in hemodialysis patients: a prospective randomized controlled trial.

Kidney research and clinical practice

Park KS, Kang EW, Chang TI, Jo W, Park JT, Yoo TH, Kang SW, Han SH.
PMID: 34370930
Kidney Res Clin Pract. 2021 Sep;40(3):445-456. doi: 10.23876/j.krcp.21.044. Epub 2021 Jul 30.

BACKGROUND: The use of newly developed mixed-dilution hemodiafiltration (HDF) can supplement the weaknesses of pre- and postdilution HDF. However, it is unclear whether mixed-HDF performs well compared to predilution HDF.METHODS: We conducted a prospective, open-labeled, randomized controlled trial from...

Cite
Park KS, Kang EW, Chang TI, et al. Mixed- versus predilution hemodiafiltration effects on convection volume and small and middle molecule clearance in hemodialysis patients: a prospective randomized controlled trial. Kidney Res Clin Pract. 2021;40(3):445-456doi: 10.23876/j.krcp.21.044.
Park, K. S., Kang, E. W., Chang, T. I., Jo, W., Park, J. T., Yoo, T. H., Kang, S. W., & Han, S. H. (2021). Mixed- versus predilution hemodiafiltration effects on convection volume and small and middle molecule clearance in hemodialysis patients: a prospective randomized controlled trial. Kidney research and clinical practice, 40(3), 445-456. https://doi.org/10.23876/j.krcp.21.044
Park, Kyoung Sook, et al. "Mixed- versus predilution hemodiafiltration effects on convection volume and small and middle molecule clearance in hemodialysis patients: a prospective randomized controlled trial." Kidney research and clinical practice vol. 40,3 (2021): 445-456. doi: https://doi.org/10.23876/j.krcp.21.044
Park KS, Kang EW, Chang TI, Jo W, Park JT, Yoo TH, Kang SW, Han SH. Mixed- versus predilution hemodiafiltration effects on convection volume and small and middle molecule clearance in hemodialysis patients: a prospective randomized controlled trial. Kidney Res Clin Pract. 2021 Sep;40(3):445-456. doi: 10.23876/j.krcp.21.044. Epub 2021 Jul 30. PMID: 34370930; PMCID: PMC8476308.
Copy Download .nbib Format: NLM
Direct writing of customized structural-color graphics with colloidal photonic inks.

Science advances

Kim JB, Chae C, Han SH, Lee SY, Kim SH.
PMID: 34818030
Sci Adv. 2021 Nov 26;7(48):eabj8780. doi: 10.1126/sciadv.abj8780. Epub 2021 Nov 24.

[Figure: see text].

Cite
Kim JB, Chae C, Han SH, et al. Direct writing of customized structural-color graphics with colloidal photonic inks. Sci Adv. 2021;7(48):eabj8780doi: 10.1126/sciadv.abj8780.
Kim, J. B., Chae, C., Han, S. H., Lee, S. Y., & Kim, S. H. (2021). Direct writing of customized structural-color graphics with colloidal photonic inks. Science advances, 7(48), eabj8780. https://doi.org/10.1126/sciadv.abj8780
Kim, Jong Bin, et al. "Direct writing of customized structural-color graphics with colloidal photonic inks." Science advances vol. 7,48 (2021): eabj8780. doi: https://doi.org/10.1126/sciadv.abj8780
Kim JB, Chae C, Han SH, Lee SY, Kim SH. Direct writing of customized structural-color graphics with colloidal photonic inks. Sci Adv. 2021 Nov 26;7(48):eabj8780. doi: 10.1126/sciadv.abj8780. Epub 2021 Nov 24. PMID: 34818030; PMCID: PMC8612532.
Copy Download .nbib Format: NLM
Low bone mineral density is associated with coronary arterial calcification progression and incident cardiovascular events in patients with chronic kidney disease.

Clinical kidney journal

Kim H, Lee J, Lee KB, Kim YH, Hong N, Park JT, Han SH, Kang SW, Choi KH, Oh KH, Yoo TH.
PMID: 35035942
Clin Kidney J. 2021 Jul 23;15(1):119-127. doi: 10.1093/ckj/sfab138. eCollection 2022 Jan.

BACKGROUND: Although it is well known that low bone mineral density (BMD) is associated with an increased risk of cardiovascular disease (CVD) and mortality in the general population, the prognostic role of bone mineral density (BMD) has not been...

Cite
Kim H, Lee J, Lee KB, et al. Low bone mineral density is associated with coronary arterial calcification progression and incident cardiovascular events in patients with chronic kidney disease. Clin Kidney J. 2021;15(1):119-127doi: 10.1093/ckj/sfab138.
Kim, H., Lee, J., Lee, K. B., Kim, Y. H., Hong, N., Park, J. T., Han, S. H., Kang, S. W., Choi, K. H., Oh, K. H., & Yoo, T. H. (2022). Low bone mineral density is associated with coronary arterial calcification progression and incident cardiovascular events in patients with chronic kidney disease. Clinical kidney journal, 15(1), 119-127. https://doi.org/10.1093/ckj/sfab138
Kim, Hyoungnae, et al. "Low bone mineral density is associated with coronary arterial calcification progression and incident cardiovascular events in patients with chronic kidney disease." Clinical kidney journal vol. 15,1 (2022): 119-127. doi: https://doi.org/10.1093/ckj/sfab138
Kim H, Lee J, Lee KB, Kim YH, Hong N, Park JT, Han SH, Kang SW, Choi KH, Oh KH, Yoo TH. Low bone mineral density is associated with coronary arterial calcification progression and incident cardiovascular events in patients with chronic kidney disease. Clin Kidney J. 2021 Jul 23;15(1):119-127. doi: 10.1093/ckj/sfab138. eCollection 2022 Jan. PMID: 35035942; PMCID: PMC8757420.
Copy Download .nbib Format: NLM
Association of Blood Pressure with Cardiovascular Outcome and Mortality: Results from the KNOW-CKD Study.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Lee JY, Park JT, Joo YS, Lee C, Yun HR, Chang TI, Kim YH, Chung W, Yoo TH, Kang SW, Park SK, Chae DW, Oh KH, Han SH.
PMID: 34473286
Nephrol Dial Transplant. 2021 Sep 02; doi: 10.1093/ndt/gfab257. Epub 2021 Sep 02.

BACKGROUND: Optimal BP control is a major therapeutic strategy to reduce adverse cardiovascular events and mortality in patients with CKD. We studied the association of BP with adverse cardiovascular outcome and all-cause death in patients with CKD.METHODS: Among 2,238...

Cite
Lee JY, Park JT, Joo YS, et al. Association of Blood Pressure with Cardiovascular Outcome and Mortality: Results from the KNOW-CKD Study. Nephrol Dial Transplant. 2021;doi: 10.1093/ndt/gfab257.
Lee, J. Y., Park, J. T., Joo, Y. S., Lee, C., Yun, H. R., Chang, T. I., Kim, Y. H., Chung, W., Yoo, T. H., Kang, S. W., Park, S. K., Chae, D. W., Oh, K. H., Han, S. H. (2021). Association of Blood Pressure with Cardiovascular Outcome and Mortality: Results from the KNOW-CKD Study. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, . https://doi.org/10.1093/ndt/gfab257
Lee, Jee Young, et al. "Association of Blood Pressure with Cardiovascular Outcome and Mortality: Results from the KNOW-CKD Study." Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association vol. (2021). doi: https://doi.org/10.1093/ndt/gfab257
Lee JY, Park JT, Joo YS, Lee C, Yun HR, Chang TI, Kim YH, Chung W, Yoo TH, Kang SW, Park SK, Chae DW, Oh KH, Han SH. Association of Blood Pressure with Cardiovascular Outcome and Mortality: Results from the KNOW-CKD Study. Nephrol Dial Transplant. 2021 Sep 02; doi: 10.1093/ndt/gfab257. Epub 2021 Sep 02. PMID: 34473286.
Copy Download .nbib Format: NLM
Diagnostic and prognostic role of nitroglycerin-induced dilation in patients with suspected vasospastic angina, combined with ergonovine provocation test.

Scientific reports

Kim M, Jang AY, Oh PC, Suh SY, Lee K, Kang WC, Ahn T, Han SH.
PMID: 34903772
Sci Rep. 2021 Dec 13;11(1):23834. doi: 10.1038/s41598-021-03338-0.

The diagnostic and prognostic role of nitroglycerin-induced dilation (NID) combined with ergonovine provocation test in patients with suspected VSA patients is not clear. A total of 438 consecutive patients who underwent the ergonovine provocation test for the diagnosis of...

Cite
Kim M, Jang AY, Oh PC, et al. Diagnostic and prognostic role of nitroglycerin-induced dilation in patients with suspected vasospastic angina, combined with ergonovine provocation test. Sci Rep. 2021;11(1):23834doi: 10.1038/s41598-021-03338-0.
Kim, M., Jang, A. Y., Oh, P. C., Suh, S. Y., Lee, K., Kang, W. C., Ahn, T., & Han, S. H. (2021). Diagnostic and prognostic role of nitroglycerin-induced dilation in patients with suspected vasospastic angina, combined with ergonovine provocation test. Scientific reports, 11(1), 23834. https://doi.org/10.1038/s41598-021-03338-0
Kim, Minsu, et al. "Diagnostic and prognostic role of nitroglycerin-induced dilation in patients with suspected vasospastic angina, combined with ergonovine provocation test." Scientific reports vol. 11,1 (2021): 23834. doi: https://doi.org/10.1038/s41598-021-03338-0
Kim M, Jang AY, Oh PC, Suh SY, Lee K, Kang WC, Ahn T, Han SH. Diagnostic and prognostic role of nitroglycerin-induced dilation in patients with suspected vasospastic angina, combined with ergonovine provocation test. Sci Rep. 2021 Dec 13;11(1):23834. doi: 10.1038/s41598-021-03338-0. PMID: 34903772; PMCID: PMC8668896.
Copy Download .nbib Format: NLM
Radiation-Inactivated .

Frontiers in immunology

Ji HJ, Byun EB, Chen F, Ahn KB, Jung HK, Han SH, Lim JH, Won Y, Moon JY, Hur J, Seo HS.
PMID: 34484221
Front Immunol. 2021 Aug 16;12:717556. doi: 10.3389/fimmu.2021.717556. eCollection 2021.

No abstract available.

Cite
Ji HJ, Byun EB, Chen F, et al. Radiation-Inactivated . Front Immunol. 2021;12:717556doi: 10.3389/fimmu.2021.717556.
Ji, H. J., Byun, E. B., Chen, F., Ahn, K. B., Jung, H. K., Han, S. H., Lim, J. H., Won, Y., Moon, J. Y., Hur, J., & Seo, H. S. (2021). Radiation-Inactivated . Frontiers in immunology, 12717556. https://doi.org/10.3389/fimmu.2021.717556
Ji, Hyun Jung, et al. "Radiation-Inactivated ." Frontiers in immunology vol. 12 (2021): 717556. doi: https://doi.org/10.3389/fimmu.2021.717556
Ji HJ, Byun EB, Chen F, Ahn KB, Jung HK, Han SH, Lim JH, Won Y, Moon JY, Hur J, Seo HS. Radiation-Inactivated . Front Immunol. 2021 Aug 16;12:717556. doi: 10.3389/fimmu.2021.717556. eCollection 2021. PMID: 34484221; PMCID: PMC8415480.
Copy Download .nbib Format: NLM
Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma.

Annals of dermatology

Rhee J, Jo J, Han SH, Kwon JM.
PMID: 33911569
Ann Dermatol. 2019 Apr;31(2):201-203. doi: 10.5021/ad.2019.31.2.201. Epub 2019 Feb 28.

No effective systemic chemotherapy is well-established in basal cell carcinoma. We report a case with three simultaneous malignancies: colon cancer, basal cell carcinoma, and smoldering multiple myeloma. The patient was treated with capecitabine and oxaliplatin after surgery for colon...

Cite
Rhee J, Jo J, Han SH, et al. Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma. Ann Dermatol. 2019;31(2):201-203doi: 10.5021/ad.2019.31.2.201.
Rhee, J., Jo, J., Han, S. H., & Kwon, J. M. (2019). Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma. Annals of dermatology, 31(2), 201-203. https://doi.org/10.5021/ad.2019.31.2.201
Rhee, Jiyoung, et al. "Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma." Annals of dermatology vol. 31,2 (2019): 201-203. doi: https://doi.org/10.5021/ad.2019.31.2.201
Rhee J, Jo J, Han SH, Kwon JM. Capecitabine Plus Oxaliplatin Combination Therapy for Basal Cell Carcinoma. Ann Dermatol. 2019 Apr;31(2):201-203. doi: 10.5021/ad.2019.31.2.201. Epub 2019 Feb 28. PMID: 33911569; PMCID: PMC7992662.
Copy Download .nbib Format: NLM
Genistein: A Potential Natural Lead Molecule for New Drug Design and Development for Treating Memory Impairment.

Molecules (Basel, Switzerland)

Fuloria S, Yusri MAA, Sekar M, Gan SH, Rani NNIM, Lum PT, Ravi S, Subramaniyan V, Azad AK, Jeyabalan S, Wu YS, Meenakshi DU, Sathasivam KV, Fuloria NK.
PMID: 35011497
Molecules. 2022 Jan 01;27(1). doi: 10.3390/molecules27010265.

Genistein is a naturally occurring polyphenolic molecule in the isoflavones group which is well known for its neuroprotection. In this review, we summarize the efficacy of genistein in attenuating the effects of memory impairment (MI) in animals. Scopus, PubMed,...

Cite
Fuloria S, Yusri MAA, Sekar M, et al. Genistein: A Potential Natural Lead Molecule for New Drug Design and Development for Treating Memory Impairment. Molecules. 2022;27(1)doi: 10.3390/molecules27010265.
Fuloria, S., Yusri, M. A. A., Sekar, M., Gan, S. H., Rani, N. N. I. M., Lum, P. T., Ravi, S., Subramaniyan, V., Azad, A. K., Jeyabalan, S., Wu, Y. S., Meenakshi, D. U., Sathasivam, K. V., & Fuloria, N. K. (2022). Genistein: A Potential Natural Lead Molecule for New Drug Design and Development for Treating Memory Impairment. Molecules (Basel, Switzerland), 27(1), . https://doi.org/10.3390/molecules27010265
Fuloria, Shivkanya, et al. "Genistein: A Potential Natural Lead Molecule for New Drug Design and Development for Treating Memory Impairment." Molecules (Basel, Switzerland) vol. 27,1 (2022). doi: https://doi.org/10.3390/molecules27010265
Fuloria S, Yusri MAA, Sekar M, Gan SH, Rani NNIM, Lum PT, Ravi S, Subramaniyan V, Azad AK, Jeyabalan S, Wu YS, Meenakshi DU, Sathasivam KV, Fuloria NK. Genistein: A Potential Natural Lead Molecule for New Drug Design and Development for Treating Memory Impairment. Molecules. 2022 Jan 01;27(1). doi: 10.3390/molecules27010265. PMID: 35011497; PMCID: PMC8746870.
Copy Download .nbib Format: NLM
Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy.

JAMA network open

Hu X, Chehal PK, Kaplan C, Krukowski RA, Lan RH, Stepanski E, Schwartzberg L, Vidal G, Graetz I.
PMID: 34061200
JAMA Netw Open. 2021 Jun 01;4(6):e2112076. doi: 10.1001/jamanetworkopen.2021.12076.

IMPORTANCE: Race disparities persist in breast cancer mortality rates. One factor associated with these disparities may be differences in symptom burden, which may reduce chemotherapy tolerance and increase early treatment discontinuation.OBJECTIVES: To compare symptom burden by race among women...

Cite
Hu X, Chehal PK, Kaplan C, et al. Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy. JAMA Netw Open. 2021;4(6):e2112076doi: 10.1001/jamanetworkopen.2021.12076.
Hu, X., Chehal, P. K., Kaplan, C., Krukowski, R. A., Lan, R. H., Stepanski, E., Schwartzberg, L., Vidal, G., & Graetz, I. (2021). Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy. JAMA network open, 4(6), e2112076. https://doi.org/10.1001/jamanetworkopen.2021.12076
Hu, Xin, et al. "Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy." JAMA network open vol. 4,6 (2021): e2112076. doi: https://doi.org/10.1001/jamanetworkopen.2021.12076
Hu X, Chehal PK, Kaplan C, Krukowski RA, Lan RH, Stepanski E, Schwartzberg L, Vidal G, Graetz I. Characterization of Clinical Symptoms by Race Among Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Before Starting Chemotherapy. JAMA Netw Open. 2021 Jun 01;4(6):e2112076. doi: 10.1001/jamanetworkopen.2021.12076. PMID: 34061200; PMCID: PMC8170541.
Copy Download .nbib Format: NLM
Showing 1141 to 1149 of 1149 entries